# AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery

> **NCT03908567** · PHASE2 · COMPLETED · sponsor: **Auris Medical AG** · enrollment: 124 (actual)

## Conditions studied

- Vestibular Vertigo

## Interventions

- **DRUG:** Intranasal Drug
- **DRUG:** Oral Tablet
- **OTHER:** Intranasal Placebo

## Key facts

- **NCT ID:** NCT03908567
- **Lead sponsor:** Auris Medical AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-18
- **Primary completion:** 2022-03-28
- **Final completion:** 2022-03-28
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2023-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03908567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03908567, "AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03908567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*